Erectile dysfunction and the risk of prostate cancer

Wei-Yu Lin; Ying-Hsu Chang; Cheng-Li Lin; Chia-Hung Kao; Hsi-Chin Wu

doi:10.18632/oncotarget.17082

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Erectile dysfunction and the risk of prostate cancer

Wei-Yu Lin, Ying-Hsu Chang, Cheng-Li Lin, Chia-Hung Kao and Hsi-Chin Wu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:52690-52698. https://doi.org/10.18632/oncotarget.17082

Metrics: PDF 1997 views | HTML 2680 views | ?

Abstract

Wei-Yu Lin1,2,3, Ying-Hsu Chang4, Cheng-Li Lin5,6, Chia-Hung Kao7,8,9 and Hsi-Chin Wu10,11

1Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Gia-Yi, Taiwan

2Chang Gung University of Science and Technology, Chia-Yi, Taiwan

3Department of Medicine, Chang Gung University, Taoyuan, Taiwan

4Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, LinKo, Taiwan

5Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan

6School of Medicine, China Medical University, Taichung, Taiwan

7Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan

8Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan

9Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan

10Department of Urology, China Medical University Hospital, Taichung, Taiwan

11Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan

Correspondence to:

Hsi-Chin Wu, email: [email protected]

Keywords: Prostate cancer (PCa), erectile dysfunction (ED), Cohort study, National Health Insurance Research Database, malignancy

Received: October 19, 2016 Accepted: March 21, 2017 Published: April 13, 2017

ABSTRACT

Background: Prostate cancer (PCa) is the most commonly diagnosed malignancy and the third leading cause of cancer death among men in developed countries. Because some risk factors are common between erectile dysfunction (ED) and PCa, we investigated the association between ED and subsequent PCa.

Methods: This nationwide population-based cohort study used data from the Taiwan National Health Insurance Research Database for the period 2000–2010. We identified patients newly diagnosed with ED by using codes from the International Classification of Diseases, Ninth Revision, Clinical Modification.

Results: In total, 5858 and 23432 patients were enrolled in the ED and non-ED cohorts, respectively. After adjustment for age, sex, and comorbidities, the overall incidence densities of PCa were significantly higher in the ED cohort than in the non-ED cohort, with an adjusted hazard ratio (aHR) of 1.19. The age-specific relative risk of PCa was significantly higher for all age groups in the ED cohort than in the non-ED cohort. Compared with patients without ED, those with organic ED had a 1.27-fold higher risk of PCa.

Conclusion: ED is a harbinger of PCa in some men. Physicians should consider the possibility of occult PCa in patients with ED regardless of age and comorbidities.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17082

Publication Alerts

Research Papers:

Erectile dysfunction and the risk of prostate cancer

Abstract